Publication Cover
Endothelium
Journal of Endothelial Cell Research
Volume 8, 2001 - Issue 3
7
Views
7
CrossRef citations to date
0
Altmetric
Original

Effects of First Generation E1E3-Deleted and Second Generation E1E3E4-Deleted/Modified Adenovirus Vectors on Human Endothelial Cell Death

, , , , , & show all
Pages 167-179 | Received 14 Aug 2000, Published online: 31 Jan 2011

References

  • Brand K., Klocke R., Pobetaling A., Paul D., Strauss M. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther. 1999; 6: 1054–1063
  • Christ M., Louis B., Stoeckel F., Dieterle A., Grave L., Dreyer D., Kintz J., Hadji D. A., Lusky M., Mehtali M. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products. Hum. Gene Ther. 2000; 11: 415–427
  • Christ M., Lusky M., Stoeckel F., Dreyer D., Dieterle A., Michou A. I., Pavirani A., Mehtali M. Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunol. Lett. 1997; 57: 19–25
  • Clesham G. J., Adam P. J., Proudfoot D., Flynn P. D., Efstathiou S., Weissberg P. L. High adenoviral loads stimulate NF kappaB-dependent gene expression in human vascular smooth muscle cells. Gene Ther. 1998; 5: 174–180
  • Dedieu J. F., Vigne E., Torrent C., Jullien C., Mahfouz I., Caillaud J. M., Aubailly N., Orsini C., Guillaume J. M., Opolon P., Delaere P., Perricaudet M., Yeh P. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J. Virol. 1997; 71: 4626–4637
  • Dobner T., Horikoshi N., Rubenwolf S., Shenk T. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 1996; 272: 1470–1473
  • Erdreich-Epstein A., Shimada H., Groshen S., Liu M., Metelitsa L. S., Kim K. S., Stins M. F., Seeger R. C., Durden D. L. Integrins alphavbeta3 and alphavbeta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res. 2000; 60: 712–721
  • Gao G. P., Yang Y., Wilson J. M. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 1996; 70: 8934–8943
  • Haimovitz-Friedman A., Cordon-Cardo C., Bayoumy S., Garzotto M., McLoughlin M., Gallily R., Edwards C. K., Schuchman E. H., Fuks Z., Kolesnick R. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J. Exp. Med. 1997; 186: 1831–1841
  • Haimovitz-Friedman A., Kan C. C., Ehleiter D., Persaud R. S., McLoughlin M., Fuks Z., Kolesnick R. N. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J. Exp. Med. 1994; 180: 525–535
  • Harada-Shiba M., Kinoshita M., Kamido H., Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J. Biol. Chem. 1998; 273: 9681–9687
  • Huang M. M., Hearing P. The adenovirus early region 4 open reading frame 6/7 protein regulates the DNA binding activity of the cellular transcription factor, E2F, through a direct complex. Genes Dev. 1989; 3: 1699–1710
  • Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973; 52: 2745–2756
  • Kolesnick R. N., Haimovitz-Friedman A., Fuks Z. The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem. Cell Biol. 1994; 72: 471–474
  • Kuhnel F, Zender L., Paul Y., Tietze M. K., Trautwein C., Manns M., Kubicka S. NFkB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis. J. Biol. Chem. 2000; 275: 6421–6427
  • Lavoie J. N., Nguyen M., Marcellus R. C., Branton P. E., Shore G. C. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J. Cell Biol. 1998; 140: 637–645
  • Lieber A., He C. Y., Meuse L., Schowalter D., Kirillova I., Winther B., Kay M. A. The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. J. Virol. 1997; 71: 8798–8807
  • Lin K. I., DiDonato J. A., Hoffmann A., Hardwick J. M., Ratan R. R. Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis. J. Cell Biol. 1998; 141: 1479–1487
  • Loser P., Jennings G. S., Strauss M., Sandig V. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J. Virol. 1998; 72: 180–190
  • Lusky M., Christ M., Rittner K., Dieterle A., Dreyer D., Mourot B., Schultz H., Stoeckel R., Pavirani A., Mehtali M. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. J. Virol. 1998; 72: 2022–2032
  • Marcellus R. C., Lavoie J. N., Boivin D., Shore G. C., Ketner G., Branton P. E. The early region 4 orf4 protein of human adenovirus type 5 induces p53- independent cell death by apoptosis. J. Virol. 1998; 72: 7144–7153
  • Marcellus R. C., Teodoro J. G., Wu T, Brough D. E., Ketner G., Shore G. C, Branton P. E. Adenovirus type 5 early region 4 is responsible for E1A-induced p53-independent apoptosis. J. Virol. 1996; 70: 6207–6215
  • Marianneau P., Cardona A., Edelman L., Deubel V., Despres P. Dengue virus replication in human hepatoma cells activates NF-kappaB which in turn induces apoptotic cell death. J. Virol. 1997; 71: 3244–3249
  • Moore M., Horikoshi N., Shenk T. Oncogenic potential of the adenovirus E4orf6 protein. Proc. Natl. Acad. Sci. USA 1996; 93: 11295–11301
  • Muller U., Kleinberger T., Shenk T. Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1. J. Virol. 1992; 66: 5867–5878
  • Ramalingam R., Rafii S., Worgall S., Brough D. E., Crystal R. G. E1-E4+ adenoviral gene transfer vectors function as a “pro-life” signal to promote survival of primary human endothelial cells. Blood 1999a; 93: 2936–2944
  • Ramalingam R., Rafii S., Worgall S., Hackett N. R., Crystal R. G. Induction of endogenous genes following infection of human endothelial cells with an E1-E4+ adenovirus gene transfer vector. J. Virol. 1999b; 73: 10183–10190
  • Robaye B., Mosselmans R., Fiers W., Dumont J. E., Galand P. Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am. J. Pathol. 1991; 138: 447–453
  • Schiavi S. C., Abdelkader N., Reber S., Pennington S., Narayana R., McPherson J. M., Smith A. E., Hoppe H., Cheng S. H. Biosynthetic and growth abnormalities are associated with high-level expression of CFTR in heterologous cells. Am. J. Physiol. 1996; 270: C341–C351
  • Stutts M. J., Gabriel S. E., Olsen J. C., Gatzy J. T., O'Connell T. L., Price E. M., Boucher R. C. Functional consequences of heterologous expression of the cystic fibrosis transmembrane conductance regulator in fibroblasts. J. Biol. Chem. 1993; 268: 20653–20658
  • Teramoto S., Johnson L. G., Huang W., Leigh M. W., Boucher R. C. Effect of adenoviral vector infection on cell proliferation in cultured primary human airway epithelial cells. Hum. Gene Ther. 1995; 6: 1045–1053
  • Teramoto S., Matsuse T, Matsui H., Ohga E., Ishii T., Ouchi Y. Recombinant E1-deleted adenovirus vector induces apoptosis in two lung cancer cell lines. Eur. Respir. J. 1999; 13: 1125–1132
  • Tousson A., Van Tine B. A., Naren A. P., Shaw G. M., Schwiebert L. M. Characterization of CFTR expression and chloride channel activity in human endothelia. Am. J. Physiol. 1998; 275: C1555–C1564
  • Weber M., Deng S., Kucher T, Shaked A., Ketchum R. J., Brayman K. L. Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function. J. Surg. Res. 1997; 69: 23–32
  • Wersto R. P., Rosenthal E. R., Seth P. K., Eissa N. T., Donahue R. E. Recombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins. J. Virol. 1998; 72: 9491–9502

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.